CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Pharmaxis Ltd Company Snapshot
Pharmaxis Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other companies in this sector in AUSTRALIA : Mesoblast Ltd (2021 sales of 9.98 million Australian Dollars [US$7.23 million] of which 100% was Adult Stem Cell Development), Idt Australia Limited. (16.93 million Australian Dollars [US$12.27 million] ), and Kazia Therapeutics Ltd (15.22 million Australian Dollars [US$11.03 million] of which 100% was Pharmacetical research and development b).

Sales Analysis. During the year ended June of 2021, sales at Pharmaxis Ltd were A$22.85 million (US$16.55 million). This is an increase of 82.0% versus 2020, when the company's sales were A$12.55 million. Sales of Mannitol saw an increase that was more than double the company's growth rate: sales were up 221.6% in 2021, from A$7.05 million to A$22.67 million. Not all segments of Pharmaxis Ltd experienced an increase in sales in 2021: sales of New Drug Development fell 89.5% to A$544,000.00 . Pharmaxis Ltd also experienced decreases in sales in Corporate (down 9.4% to A$416,000.00 ) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Pharmaxis Ltd
  Stock Performance Chart for Pharmaxis Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/24/2021): .13
(Figures in Australian Dollars)
1 Week -12.1%   13 Weeks 15.9%  
4 Weeks 65.6%   52 Weeks 51.8%  
 
Pharmaxis Ltd Key Data:
  Ticker: PXS Country: Australia
  Exchanges: OTC BLN ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2021 Sales 22,845,000
(Year Ending Jan 2022).
Employees: 107
  Currency: Australian Dollars Market Cap: 57,735,081
  Fiscal Yr Ends: June Shares Outstanding: 452,824,164
  Share Type: Ordinary Closely Held Shares: 36,943,405
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.